国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Staphylococcus epidermidis PTS system lactose-specific EIICB component (lacE), partial CSB-YP817243SLD
CSB-EP817243SLD
CSB-BP817243SLD
CSB-MP817243SLD
CSB-EP817243SLD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus epidermidis Phosphopentomutase (deoB) CSB-YP817244SLD
CSB-EP817244SLD
CSB-BP817244SLD
CSB-MP817244SLD
CSB-EP817244SLD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus epidermidis ATP synthase subunit b (atpF), partial CSB-YP817245SLD1
CSB-EP817245SLD1
CSB-BP817245SLD1
CSB-MP817245SLD1
CSB-EP817245SLD1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus epidermidis ATP synthase epsilon chain (atpC) CSB-YP817246SLD
CSB-EP817246SLD
CSB-BP817246SLD
CSB-MP817246SLD
CSB-EP817246SLD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus epidermidis Holo-[acyl-carrier-protein] synthase (acpS) CSB-YP817247SLD
CSB-EP817247SLD
CSB-BP817247SLD
CSB-MP817247SLD
CSB-EP817247SLD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus epidermidis Dihydroxy-acid dehydratase (ilvD), partial CSB-YP817248SLD
CSB-EP817248SLD
CSB-BP817248SLD
CSB-MP817248SLD
CSB-EP817248SLD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus epidermidis NH (3)-dependent NAD (+) synthetase (nadE) CSB-YP817249SLD
CSB-EP817249SLD
CSB-BP817249SLD
CSB-MP817249SLD
CSB-EP817249SLD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus epidermidis Peroxide-responsive repressor perR (perR) CSB-YP817250SLD
CSB-EP817250SLD
CSB-BP817250SLD
CSB-MP817250SLD
CSB-EP817250SLD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus epidermidis Probable catabolite control protein A (ccpA) CSB-YP817251SLD
CSB-EP817251SLD
CSB-BP817251SLD
CSB-MP817251SLD
CSB-EP817251SLD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus epidermidis Isocitrate dehydrogenase [NADP] (icd) CSB-YP817252SLD
CSB-EP817252SLD
CSB-BP817252SLD
CSB-MP817252SLD
CSB-EP817252SLD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus epidermidis Glutamate-1-semialdehyde 2,1-aminomutase 1 (hemL1) CSB-YP817253SLD
CSB-EP817253SLD
CSB-BP817253SLD
CSB-MP817253SLD
CSB-EP817253SLD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus epidermidis 5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase (mtnN) CSB-YP817254SLD
CSB-EP817254SLD
CSB-BP817254SLD
CSB-MP817254SLD
CSB-EP817254SLD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus epidermidis GTPase Era (era) CSB-YP817255SLD
CSB-EP817255SLD
CSB-BP817255SLD
CSB-MP817255SLD
CSB-EP817255SLD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus epidermidis Exodeoxyribonuclease 7 small subunit (xseB) CSB-YP817256SLD
CSB-EP817256SLD
CSB-BP817256SLD
CSB-MP817256SLD
CSB-EP817256SLD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus epidermidis Chorismate synthase (aroC) CSB-YP817257SLD
CSB-EP817257SLD
CSB-BP817257SLD
CSB-MP817257SLD
CSB-EP817257SLD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus epidermidis Response regulator ArlR (arlR) CSB-YP817258SLD
CSB-EP817258SLD
CSB-BP817258SLD
CSB-MP817258SLD
CSB-EP817258SLD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus epidermidis Dihydrodipicolinate reductase (dapB) CSB-YP817259SLD
CSB-EP817259SLD
CSB-BP817259SLD
CSB-MP817259SLD
CSB-EP817259SLD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus epidermidis Aminoacyltransferase FemA (femA) CSB-YP817260SLD
CSB-EP817260SLD
CSB-BP817260SLD
CSB-MP817260SLD
CSB-EP817260SLD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus epidermidis Probable tautomerase SE_1045 (SE_1045) CSB-YP817261SLD
CSB-EP817261SLD
CSB-BP817261SLD
CSB-MP817261SLD
CSB-EP817261SLD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus epidermidis Catalase (katA), partial CSB-YP817262SLD
CSB-EP817262SLD
CSB-BP817262SLD
CSB-MP817262SLD
CSB-EP817262SLD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>